China: The Next Pharmacy of the World?

完整後設資料紀錄

DC 欄位	值	語言
dc.contributor.author	Chen, Feng-Chi	en_US
dc.date.accessioned	2019-04-02T06:00:43Z	-
dc.date.available	2019-04-02T06:00:43Z	-
dc.date.issued	2018-10-01	en_US
dc.identifier.issn	0165-6147	en_US
dc.identifier.uri	http://dx.doi.org/10.1016/j.tips.2018.07.004	en_US
dc.identifier.uri	http://hdl.handle.net/11536/148173	-
dc.description.abstract	The manufacturing success in China has not yet radiated to the pharmaceutical sector. Recently, China released a policy guideline to foster its follow-on drug industry, revealing its ambition to become a great power in the field. Here, I briefly discuss how this guideline may change the industry landscape, and its associated challenges and opportunities.	en_US
dc.language.iso	en_US	en_US
dc.title	China: The Next Pharmacy of the World?	en_US
dc.type	Article	en_US
dc.identifier.doi	10.1016/j.tips.2018.07.004	en_US
dc.identifier.journal	TRENDS IN PHARMACOLOGICAL SCIENCES	en_US
dc.citation.volume	39	en_US
dc.citation.spage	843	en_US
dc.citation.epage	848	en_US
dc.contributor.department	生物科技學系	zh_TW
dc.contributor.department	科技法律學院	zh_TW
dc.contributor.department	Department of Biological Science and Technology	en_US
dc.contributor.department	College of Law	en_US
dc.identifier.wosnumber	WOS:000445117100001	en_US
dc.citation.woscount	0	en_US
顯示於類別：	期刊論文